Sartorius AG

The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions complementary technologies. In fiscal 2020, the company earned sales revenue of some 2.34 billion euros. At the end of 2020, nearly 11,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.

Whitepaper: Phenotypic and functional CAR-T cell characterisation

Whitepaper: Accelerate antibody screening and characterisation

Whitepaper: Characterising astroglia models

Handbook: Latest edition live-cell analysis

Whitepaper: Understanding T Cell phenotype and function

Product hub: Octet^® R series systems

Brochure: NEW! Upgradeable label-free biomolecular analysis

Guidelines: 21 CFR Part 11 Compliance Checklist

Application note: Integration of Sartorius Cubis^® II Premium Balances into STARLIMS™ from Abbott Informatics

Whitepaper: Cubis^® II pharma compliant by design

An IgM antibody platform to tackle SARS-CoV-2 and its variants

ebook: Antibody Discovery – technology and techniques to boost development

Sartorius releases the fifth edition of its popular Live-Cell Analysis Handbook

Utilising synthetic DNA technologies for high-throughput antibody discovery and optimisation